Vidcast:
https://youtu.be/S9WDXawVQMQ Systemic therapy with estrogens, progesterones, or a combination of both can more than double a post-menopausal woman’s risk of developing breast cancer. This frightening warning comes from a collaborative study just published in The Lancet. The research focused on nearly 107,000 postmenopausal breast cancer patients half of whom had received hormonal therapy. The more hormones a woman receives and the longer she receives them will drive up the risk
...
Más informaciones
of cancer from a low of 17% for a 1-4 year course of estrogen alone up to 230% for estrogen-progestin combo therapy taken for 5-14 years. The only hormonal therapy that did not increase cancer risk was topical vaginal therapy. This sobering study is proof positive that menopausal systemic hormonal therapy is dangerous. Women suffering from severe menopausal symptoms have found significant relief from moisturizing topical agents, counseling, anti-depressants, Vitamin E, and acupuncture. Raja Dhar et al. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet, 2019 DOI: 10.1016/S0140-6736(19)31709-X https://ww5.komen.org/BreastCancer/AlternativestoPostmenopausalHormones.html #Menopause #hormonaltherapy #MHT #cancer #breast
